Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 1
1981 1
1990 1
1992 1
1993 1
1994 1
2012 1
2013 1
2014 2
2015 1
2017 1
2018 2
2019 1
2021 4
2022 6
2023 4
2024 6
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean m zarrei (5 results)?
Non-coding RNA-Mediated N6-Methyladenosine (m(6)A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response.
Hashemi M, Daneii P, Zandieh MA, Raesi R, Zahmatkesh N, Bayat M, Abuelrub A, Khazaei Koohpar Z, Aref AR, Zarrabi A, Rashidi M, Salimimoghadam S, Entezari M, Taheriazam A, Khorrami R. Hashemi M, et al. Noncoding RNA Res. 2023 Nov 13;9(1):84-104. doi: 10.1016/j.ncrna.2023.11.005. eCollection 2024 Mar. Noncoding RNA Res. 2023. PMID: 38075202 Free PMC article. Review.
The emergence of RNA modifications has recently been considered as critical post-transcriptional regulations which governed gene expression. N(6)-methyladenosine (m(6)A) modification is the most abundant type of RNA modification which is mediated by three distinct classes …
The emergence of RNA modifications has recently been considered as critical post-transcriptional regulations which governed gene expression. …
Bioprinted Membranes for Corneal Tissue Engineering: A Review.
Orash Mahmoud Salehi A, Heidari-Keshel S, Poursamar SA, Zarrabi A, Sefat F, Mamidi N, Behrouz MJ, Rafienia M. Orash Mahmoud Salehi A, et al. Pharmaceutics. 2022 Dec 14;14(12):2797. doi: 10.3390/pharmaceutics14122797. Pharmaceutics. 2022. PMID: 36559289 Free PMC article. Review.
Transition Metal Dichalcogenides (TMDC)-Based Nanozymes for Biosensing and Therapeutic Applications.
Presutti D, Agarwal T, Zarepour A, Celikkin N, Hooshmand S, Nayak C, Ghomi M, Zarrabi A, Costantini M, Behera B, Maiti TK. Presutti D, et al. Materials (Basel). 2022 Jan 4;15(1):337. doi: 10.3390/ma15010337. Materials (Basel). 2022. PMID: 35009484 Free PMC article. Review.
In particular, transition metal dichalcogenides (TMDCs, with the general formula MX(2), where M represents a transition metal and X is a chalcogen element)-based nanozymes have demonstrated exceptional potential in the healthcare and diagnostic sectors. ...
In particular, transition metal dichalcogenides (TMDCs, with the general formula MX(2), where M represents a transition metal and X i …
REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimens.
Zhong J, Jang A, Abuqayas B, Basu A, Benjamin DJ, Bhatlapenumarthi V, Bilen MA, Buch D, Chang M, Chin E, Darabi S, Dhanikonda N, Ghatalia P, Grigg CM, Grier AL, Jindal T, Jung J, Kilari D, Kumar HLS, Lee S, Neelands B, Pandya C, Pawalek J, Staggers J, Yildirim A, Zakharia Y, Zarrabi KK, Zimmerman M, Sledge G, Spetzler D, Elliott A, McKay RR, Barata PC. Zhong J, et al. Oncologist. 2025 Jun 4;30(6):oyaf135. doi: 10.1093/oncolo/oyaf135. Oncologist. 2025. PMID: 40536267 Free PMC article.
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes.
Zorko NA, Makovec A, Elliott A, Kellen S, Lozada JR, Arafa AT, Felices M, Shackelford M, Barata P, Zakharia Y, Narayan V, Stein MN, Zarrabi KK, Patnaik A, Bilen MA, Radovich M, Sledge G, El-Deiry WS, Heath EI, Hoon DSB, Nabhan C, Miller JS, Hwang JH, Antonarakis ES. Zorko NA, et al. Prostate Cancer Prostatic Dis. 2025 Mar;28(1):129-137. doi: 10.1038/s41391-024-00797-0. Epub 2024 Feb 28. Prostate Cancer Prostatic Dis. 2025. PMID: 38418892 Free PMC article.
A novel missense mutation in oncostatin M receptor beta causing primary localized cutaneous amyloidosis.
Saeedi M, Ebrahim-Habibi A, Haghighi A, Zarrabi F, Amoli MM, Robati RM. Saeedi M, et al. Biomed Res Int. 2014;2014:653724. doi: 10.1155/2014/653724. Epub 2014 Jun 26. Biomed Res Int. 2014. PMID: 25054142 Free PMC article.
Autosomal dominant PLCA has been mapped earlier to pathogenic missense mutations in the OSMR gene, which encodes the oncostatin M receptor ss subunit (OSMRss). OSMRss is interleukin-6 family cytokine receptors and possesses two ligands, oncostatin M and interleukin- …
Autosomal dominant PLCA has been mapped earlier to pathogenic missense mutations in the OSMR gene, which encodes the oncostatin M rec …
35 results